GUGGENHEIM CAPITAL LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 50 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$35,000
+40.0%
10,390
-11.1%
0.00%
Q3 2017$25,000
-13.8%
11,688
-0.2%
0.00%
Q2 2017$29,000
+7.4%
11,7090.0%0.00%
Q1 2017$27,000
+145.5%
11,709
+0.6%
0.00%
Q4 2016$11,000
-15.4%
11,6390.0%0.00%
Q3 2016$13,000
-91.7%
11,639
+2.0%
0.00%
Q2 2014$157,000
-2.5%
11,406
+8.4%
0.00%
Q1 2014$161,00010,5230.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$271,9250.08%
Geneos Wealth Management Inc. 427,400$897,5400.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$25,2000.02%
Vivaldi Capital Management LP 19,261$40,4480.01%
Beacon Capital Management, LLC 12,605$26,4710.01%
Atria Wealth Solutions, Inc. 263,300$552,9300.01%
Wealthspire Advisors, LLC 183,862$386,1110.01%
BARRETT & COMPANY, INC. 4,984$10,4660.01%
OSAIC HOLDINGS, INC. 1,271,760$2,670,6560.01%
Ameritas Advisory Services, LLC 45,302$94,8560.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders